Puretech Health (PRTC) Receives “Buy” Rating from Numis Securities

Numis Securities restated their buy rating on shares of Puretech Health (LON:PRTC) in a report released on Tuesday. They currently have a GBX 259 ($3.58) price target on the stock.

Several other analysts have also commented on the company. Peel Hunt reaffirmed a buy rating and issued a GBX 302 ($4.17) price objective on shares of Puretech Health in a report on Tuesday, December 19th. Liberum Capital reaffirmed a buy rating and issued a GBX 248 ($3.43) price objective on shares of Puretech Health in a report on Thursday, November 30th. N+1 Singer reaffirmed a buy rating on shares of Puretech Health in a report on Thursday, November 30th. Finally, Jefferies Group reaffirmed a buy rating on shares of Puretech Health in a report on Friday, November 17th. Five investment analysts have rated the stock with a buy rating, The company presently has an average rating of Buy and a consensus price target of GBX 260.20 ($3.59).

Shares of Puretech Health (LON PRTC) opened at GBX 173.50 ($2.40) on Tuesday. Puretech Health has a fifty-two week low of GBX 110 ($1.52) and a fifty-two week high of GBX 183.50 ($2.54). The company has a market capitalization of $412.03 and a price-to-earnings ratio of -913.16.

COPYRIGHT VIOLATION WARNING: “Puretech Health (PRTC) Receives “Buy” Rating from Numis Securities” was published by BBNS and is owned by of BBNS. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://baseballnewssource.com/markets/puretech-health-prtc-receives-buy-rating-from-numis-securities/1912414.html.

Puretech Health Company Profile

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Analyst Recommendations for Puretech Health (LON:PRTC)

Receive News & Ratings for Puretech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.